Onkure Therapeutics Inc (OKUR)

Apr 10, 2026

Revenue Check: Whats the profit margin of OnKure Therapeutics Inc2026 Volume Leaders & Growth-Oriented Investment Plans - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Growth Recap: Is Vistra Corp gaining market shareQuarterly Trade Summary & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn

Apr 09, 2026

Apr 07, 2026

Access Industries (OKUR) discloses 19.99% OnKure stake and board right - Stock Titan

Apr 07, 2026

Apr 07, 2026

StepStone affiliates report 2.66M shares in OnKure (NASDAQ: OKUR) - Stock Titan

Apr 07, 2026

Apr 07, 2026

RA Capital group reports 9.99% stake in OnKure (NASDAQ: OKUR) - Stock Titan

Apr 07, 2026

Apr 07, 2026

Trails Edge holds 6.0% of OnKure (NASDAQ: OKUR) after private placement - Stock Titan

Apr 07, 2026

Apr 07, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Apr 07, 2026

Apr 07, 2026

Trading Recap: Whats the profit margin of OnKure Therapeutics Inc2026 Biggest Moves & AI Driven Price Forecasts - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

LifeSci Capital Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Cuts Target Price to $16 - 富途牛牛

Apr 06, 2026

Apr 04, 2026

Breakouts Watch: Can OnKure Therapeutics Inc deliver consistent EPS growthDay Trade & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Apr 04, 2026

Apr 04, 2026

OKUR SEC FilingsOnKure Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 04, 2026

Apr 03, 2026

OnKure (OKUR) CEO Nicholas Saccomano awarded 330,000 stock options - Stock Titan

Apr 03, 2026

Apr 03, 2026

OnKure (OKUR) CFO granted 110,000 stock options at $4.07 - Stock Titan

Apr 03, 2026

Apr 03, 2026

OnKure Therapeutics (OKUR) awards 110,000 options to Chief Scientific Officer - Stock Titan

Apr 03, 2026

Apr 03, 2026

OnKure (OKUR) grants CMO 110,000 stock options at $4.07 strike - Stock Titan

Apr 03, 2026

Apr 01, 2026

OnKure (OKUR) director receives 15,300 stock options at $4.14 strike price - Stock Titan

Apr 01, 2026

Apr 01, 2026

OnKure Therapeutics (OKUR) director Liam Ratcliffe submits Form 3 insider report - Stock Titan

Apr 01, 2026

Apr 01, 2026

Acorn funds and Anders Hove disclose stakes in OnKure (NASDAQ: OKUR) up to 9.5% - Stock Titan

Apr 01, 2026

Mar 30, 2026

Leerink cuts OnKure stock price target on strategic shift By Investing.com - Investing.com Canada

Mar 30, 2026

Mar 30, 2026

Leerink cuts OnKure stock price target on strategic shift - investing.com

Mar 30, 2026

Mar 30, 2026

OnKure Announces $150M Private Placement and Board Changes - TipRanks

Mar 30, 2026

Mar 30, 2026

OnKure elects Dr. Liam Ratcliffe as director under Lead Investor designation - TradingView — Track All Markets

Mar 30, 2026

Mar 30, 2026

OnKure (NASDAQ: OKUR) secures $150M private placement and refocuses PI3Kα pipeline - Stock Titan

Mar 30, 2026

Mar 29, 2026

Panic Selling: Whats the profit margin of OnKure Therapeutics IncTake Profit & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 29, 2026

Mar 29, 2026

OnKure Therapeutics Sees Volatile Trading Amid Recent Developments - timothysykes.com

Mar 29, 2026

Mar 28, 2026

OKUR Shares Face Turbulence Amid Financial Downturn - StocksToTrade

Mar 28, 2026

Mar 28, 2026

OnKure Therapeutics Inc. Sees Variable Performance Amid Market Fluctuations - timothysykes.com

Mar 28, 2026

Mar 28, 2026

OnKure to sell $150M in stock to fund drug development - Daily Camera

Mar 28, 2026

Mar 28, 2026

OnKure raises $150M to advance breast cancer programs By Investing.com - Investing.com Australia

Mar 28, 2026

Mar 27, 2026

OnKure Therapeutics prices $150M oversubscribed private placement - MSN

Mar 27, 2026

Mar 27, 2026

Oppenheimer reiterates OnKure stock rating on pipeline shift By Investing.com - Investing.com India

Mar 27, 2026

Mar 27, 2026

Oppenheimer reiterates OnKure stock rating on pipeline shift - Investing.com

Mar 27, 2026

Mar 27, 2026

Aug Wrap: Is OnKure Therapeutics Inc in a bullish channelWeekly Investment Recap & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

OnKure Therapeutics, Inc. announced that it expects to receive $149.999126 million in funding from a group of investors - marketscreener.com

Mar 27, 2026

Mar 27, 2026

OnKure Therapeutics Stock Fluctuates With Market Shifts - StocksToTrade

Mar 27, 2026

Mar 27, 2026

Unprecedented Gains: OKUR Clinches Pivotal Industry Deal - timothysykes.com

Mar 27, 2026

Mar 27, 2026

Onkure Therapeutics to advance next-generation PI3Kα pan-mutant programs - BioWorld News

Mar 27, 2026

Mar 27, 2026

OnKure raises $150M to advance breast cancer programs - Investing.com

Mar 27, 2026

Mar 27, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 27, 2026

Mar 27, 2026

OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies - GlobeNewswire

Mar 27, 2026

Mar 26, 2026

Access BiotechnologyFinancial Details - Crunchbase

Mar 26, 2026

Mar 25, 2026

OnKure Therapeutics CEO Saccomano sells $357 in stock By Investing.com - Investing.com Australia

Mar 25, 2026

Mar 24, 2026

OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Down 85.2% in March - marketbeat.com

Mar 24, 2026

Mar 24, 2026

OnKure Therapeutics CFO Leverone sells $1.2k in shares - Investing.com UK

Mar 24, 2026

Mar 24, 2026

OnKure Therapeutics CFO Leverone sells $1.2k in shares By Investing.com - Investing.com Australia

Mar 24, 2026